Literature DB >> 27338833

Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome.

Lauren J Rice1,2, Jim Lagopoulos1,3, Michael Brammer4, Stewart L Einfeld1,2.   

Abstract

Prader-Willi syndrome (PWS) is characterized by infantile hypotonia, hypogonadism, small hands and feet, distinct facial features and usually intellectual impairment. The disorder is associated with severe behavioral disturbances which include hyperphagia leading to morbid obesity, temper outbursts, skin-picking, and compulsive behaviors. While the brain mechanisms that underpin these disturbances are unknown these behaviors suggest a lack of inhibition and thus gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter may be implicated. In the present study, we investigated in vivo brain GABA and its relationship with emotion and behavior in individuals with PWS. Single voxel proton magnetic resonance spectroscopy (1H-MRS) was performed on 15 individuals with PWS and 15 age- and gender-matched typically developing controls. GABA levels were measured in the parieto-occipital lobe. All other metabolite levels (N-acetyl aspartate, myo-Inositol, glutathione, glutamate, and glutamine + glutamate) were measured in the anterior cingulate cortex (ACC). GABA levels were significantly lower in the participants with PWS who had clinically significant emotional and behavioral problems relative to typically developing control participants and participants with PWS who did not have emotional and behavioral problems within the clinically significant range. GABA levels were negatively correlated with total behavioral problem scores as well as temper outbursts, skin-picking, depression, social relating difficulties, and a tendency to be self-absorbed. Our data suggests that alterations of the GABAergic system may play an important role in aspects of the pathophysiology of PWS. Pathological mechanism found in PWS may be relevant to understanding the control of similar behaviors in the general population.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  GABA; Prader-Willi syndrome; depression; magnetic resonance spectroscopy; skin-picking; temper outbursts

Mesh:

Substances:

Year:  2016        PMID: 27338833     DOI: 10.1002/ajmg.b.32472

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  8 in total

Review 1.  Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal males.

Authors:  O B Akinola; M O Gabriel
Journal:  Metab Brain Dis       Date:  2017-12-11       Impact factor: 3.584

2.  Autistic, Aberrant, and Food-Related Behaviors in Adolescents and Young Adults with Prader-Willi Syndrome: The Effects of Age and Genotype.

Authors:  Atsushi Ishii; Hiroshi Ihara; Hiroyuki Ogata; Masayuki Sayama; Masao Gito; Nobuyuki Murakami; Tadayuki Ayabe; Yuji Oto; Asami Takahashi; Toshiro Nagai
Journal:  Behav Neurol       Date:  2017-12-26       Impact factor: 3.342

Review 3.  Role of magnetic resonance spectroscopy in cerebral glutathione quantification for youth mental health: A systematic review.

Authors:  Emily Fisher; John Gillam; Rachel Upthegrove; Sarah Aldred; Stephen J Wood
Journal:  Early Interv Psychiatry       Date:  2019-05-31       Impact factor: 2.732

Review 4.  Epigenetics in Prader-Willi Syndrome.

Authors:  Aron Judd P Mendiola; Janine M LaSalle
Journal:  Front Genet       Date:  2021-02-15       Impact factor: 4.599

5.  Dietary Conjugated Linoleic Acid Reduces Body Weight and Fat in Snord116m+/p- and Snord116m-/p- Mouse Models of Prader-Willi Syndrome.

Authors:  Brittney Knott; Matthew A Kocher; Henry A Paz; Shelby E Hamm; William Fink; Jordan Mason; Robert W Grange; Umesh D Wankhade; Deborah J Good
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

6.  A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome.

Authors:  Virginia Kimonis; Abhilasha Surampalli; Marie Wencel; June-Anne Gold; Neil M Cowen
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

7.  Transcutaneous vagus nerve stimulation (t-VNS): A novel effective treatment for temper outbursts in adults with Prader-Willi Syndrome indicated by results from a non-blind study.

Authors:  Katherine E Manning; Jessica A Beresford-Webb; Lucie C S Aman; Howard A Ring; Peter C Watson; Stephen W Porges; Chris Oliver; Sally R Jennings; Anthony J Holland
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

8.  Defining Mental and Behavioural Disorders in Genetically Determined Neurodevelopmental Syndromes with Particular Reference to Prader-Willi Syndrome.

Authors:  Anthony J Holland; Lucie C S Aman; Joyce E Whittington
Journal:  Genes (Basel)       Date:  2019-12-09       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.